""

Events

Welcome to our upcoming events, please scroll down to view your city's upcoming events and click on register now for more information or to register for the event. 

Please note that this page is only for healthcare professionals (HCPs). Do not share this page with your patients or the public.

If you have any questions please email us and ensure you include your name, location and the event you are enquiring about. 

Dexcom ONE+ Sensor

ATTD-ASIA

9 - 11 December 2025
Singapore

Dexcom is exhibiting at this event (booth #01) and hosting
a symposium.

Title: Advancing Personalised Care: AI Meets CGM in
Type 2 Diabetes
Date: Wednesday, 10th December
Time: 3.50 pm - 4.50 pm
Location: Nicoll 1

 Always read the label and follow directions for use. Read the warnings available on nzmsdiabetes.co.nz/resources before purchasing. Consult your healthcare professional to see if this product is right for you.
 
Dexcom CGM is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated. Tandem t:slim X2 insulin pump with Control-IQ provides a continuous delivery of insulin through a subcutaneously applied infusion set. The algorithm will adjust insulin delivery according to the predicted glucose when used with a compatible CGM.
 
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom G6, Dexcom G7, Dexcom ONE+, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2024 Dexcom, Inc. All rights reserved.

Tandem t:slim X2 insulin pump with Control-IQ provides a continuous delivery of insulin through a subcutaneously applied infusion set. The algorithm will adjust insulin delivery according to the predicted glucose when used with a compatible CGM.
Tandem t:slim X2 insulin pump with Basal-IQ provides continuous delivery of insulin through a subcutaneously applied infusion set. The algorithm will stop insulin delivery according to the predictive low glucose when used with a compatible CGM.

 
© 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Control-IQ, and t:slim X2 are registered trademarks or trademarks of Tandem Diabetes Care, Inc.
 
NZMS is a Dexcom company.

MAT-5739